Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Kidney Transplantation

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 86 articles:
HTML format
Text format



Single Articles


    September 2019

  1. Angel-Korman A, Stern L, Sarosiek S, et al. Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int. 2019;95:405-411.
    Kidney Int. 2019;96:796.
    PubMed     Text format    


    August 2019
  2. DUPONT V, Colosio C, Hureaux M, Mokri L, et al
    The Case | Severe hypertension and hyperkalemia in a kidney transplant recipient.
    Kidney Int. 2019;96:529-530.
    PubMed     Text format    


  3. PHILIP NM, Naranje P, Bagchi S, Das CJ, et al
    Multiple abscesses in a renal transplant recipient.
    Kidney Int. 2019;96:526.
    PubMed     Text format    


    July 2019
  4. CHADBAN S, Tedesco-Silva H
    ATHENA: wisdom and warfare in defining the role of de novo mTOR inhibition in kidney transplantation.
    Kidney Int. 2019;96:27-30.
    PubMed     Text format     Abstract available


  5. KAUNDAL U, Ramachandran R, Arora A, Kenwar DB, et al
    B cells: a new player in mesenchymal stromal cell-mediated immune modulation in renal transplant patients.
    Kidney Int. 2019;96:249-250.
    PubMed     Text format    


    June 2019
  6. RANGASWAMI J, Bangalore S, Kaplan B, Birdwell KA, et al
    Cardiovascular disease care fragmentation in kidney transplantation: a call for action.
    Kidney Int. 2019 Jun 10. pii: S0085-2538(19)30586.
    PubMed     Text format    


    May 2019
  7. DRIOLLET B, Bayer F, Chatelet V, Macher MA, et al
    Social deprivation is associated with poor kidney transplantation outcome in children.
    Kidney Int. 2019 May 28. pii: S0085-2538(19)30530.
    PubMed     Text format     Abstract available


    April 2019
  8. FORMAN C, Sran H, Wafi A
    Delayed stricture of irradiated iliac arteries after renal transplantation mimicking transplant renal artery stenosis.
    Kidney Int. 2019;95:999.
    PubMed     Text format    


  9. D'AMBROSIO R, Vinci M, Franchina M, Parlati L, et al
    Effectiveness and safety of sofosbuvir-based direct-acting antiviral combinations in HCV-2 and HCV-3 kidney transplant recipients.
    Kidney Int. 2019;95:993-995.
    PubMed     Text format    


  10. BARBOUR S, Djurdjev O, Gill JS, Dong JJ, et al
    A propensity score matched analysis shows no adverse effect of early steroid withdrawal in non-diabetic kidney transplant recipients with and without glomerulonephritis.
    Kidney Int. 2019 Apr 1. pii: S0085-2538(19)30388.
    PubMed     Text format     Abstract available


  11. GLASSOCK RJ
    Evaluation of living donors: quo vadis for GFR criteria?
    Kidney Int. 2019;95:738-740.
    PubMed     Text format     Abstract available


    March 2019
  12. TAYLOR DM, Bradley JA, Bradley C, Draper H, et al
    Limited health literacy is associated with reduced access to kidney transplantation.
    Kidney Int. 2019 Mar 27. pii: S0085-2538(19)30049.
    PubMed     Text format     Abstract available


  13. CHERUKURI A, Mehta R, Sharma A, Sood P, et al
    Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
    Kidney Int. 2019 Mar 20. pii: S0085-2538(19)30176.
    PubMed     Text format     Abstract available


  14. FU R, Kim SJ, de Oliveira C, Coyte PC, et al
    An instrumental variable approach quantifies and confirms the duration of pre-transplant dialysis has negative impact on kidney transplant recipient survival.
    Kidney Int. 2019 Mar 19. pii: S0085-2538(19)30323.
    PubMed     Text format     Abstract available


  15. LEFAUCHEUR C, Viglietti D, Bouatou Y, Philippe A, et al
    Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Kidney Int. 2019 Mar 15. pii: S0085-2538(19)30173.
    PubMed     Text format     Abstract available


  16. OTTLEWSKI I, Munch J, Wagner T, Schonauer R, et al
    Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease.
    Kidney Int. 2019 Mar 15. pii: S0085-2538(19)30187.
    PubMed     Text format     Abstract available


  17. SNANOUDJ R, Kamar N, Cassuto E, Caillard S, et al
    Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.
    Kidney Int. 2019 Mar 5. pii: S0085-2538(19)30115.
    PubMed     Text format     Abstract available


  18. EVENEPOEL P, Claes K, Meijers B, Laurent MR, et al
    Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30105.
    PubMed     Text format     Abstract available


    February 2019
  19. FRIBOURG M, Anderson L, Fischman C, Cantarelli C, et al
    T-cell exhaustion correlates with improved outcomes in kidney transplant recipients.
    Kidney Int. 2019 Feb 27. pii: S0085-2538(19)30192.
    PubMed     Text format     Abstract available


  20. SOMMERER C, Suwelack B, Dragun D, Schenker P, et al
    An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.
    Kidney Int. 2019 Feb 27. pii: S0085-2538(19)30193.
    PubMed     Text format     Abstract available


  21. WEWERS TM, Mayer AB, Pfleiderer A, Beul K, et al
    Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation.
    Kidney Int. 2019 Feb 22. pii: S0085-2538(18)30901.
    PubMed     Text format     Abstract available


  22. NUVOLONE M, Merlini G
    Improved outcomes for kidney transplantation in AL amyloidosis: impact on practice.
    Kidney Int. 2019;95:258-260.
    PubMed     Text format     Abstract available


  23. SUMMERS DM, Pettigrew GJ
    Uncontrolled DCD donation-tilting at windmills or pushing against an open door?
    Kidney Int. 2019;95:263-265.
    PubMed     Text format     Abstract available


    January 2019
  24. SMITH SF, Hosgood SA, Nicholson ML
    Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells.
    Kidney Int. 2019;95:50-56.
    PubMed     Text format     Abstract available


  25. DOTIS J, Printza N, Stabouli S, Karava V, et al
    Disseminated mucormycosis in an adolescent kidney transplant recipient.
    Kidney Int. 2019;95:236.
    PubMed     Text format    


  26. EVERSON L, Bernstein BS, Chatterjee D, Lindsey B, et al
    ThINK before living donor transplantation.
    Kidney Int. 2019;95:237.
    PubMed     Text format    


  27. HALL IE, Akalin E, Bromberg JS, Doshi MD, et al
    Deceased-donor acute kidney injury is not associated with kidney allograft failure.
    Kidney Int. 2019;95:199-209.
    PubMed     Text format     Abstract available


    December 2018
  28. ANGEL-KORMAN A, Stern L, Sarosiek S, Sloan JM, et al
    Long-term outcome of kidney transplantation in AL amyloidosis.
    Kidney Int. 2018 Dec 20. pii: S0085-2538(18)30774.
    PubMed     Text format     Abstract available


  29. DEL RIO F, Andres A, Padilla M, Sanchez-Fructuoso AI, et al
    Kidney transplantation from donors after uncontrolled circulatory death: the Spanish experience.
    Kidney Int. 2018 Dec 19. pii: S0085-2538(18)30717.
    PubMed     Text format     Abstract available


  30. ERPICUM P, Weekers L, Detry O, Bonvoisin C, et al
    Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study.
    Kidney Int. 2018 Dec 6. pii: S0085-2538(18)30712.
    PubMed     Text format     Abstract available


  31. KOPP JB
    Expanding the spectrum of APOL1-related renal disease: de novo collapsing glomerulopathy following kidney transplant.
    Kidney Int. 2018;94:1048-1050.
    PubMed     Text format     Abstract available


  32. SAMPATHKUMAR K, Mukuntharajan T, Rajiv A, Anandan S, et al
    Acute page kidney phenomenon following renal allograft biopsy.
    Kidney Int. 2018;94:1241.
    PubMed     Text format    


    November 2018
  33. JOHNSON SC, Martinez F, Bitto A, Gonzalez B, et al
    mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.
    Kidney Int. 2018 Nov 21. pii: S0085-2538(18)30645.
    PubMed     Text format     Abstract available


  34. YAZDANI S, Callemeyn J, Gazut S, Lerut E, et al
    Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
    Kidney Int. 2018 Nov 2. pii: S0085-2538(18)30630.
    PubMed     Text format     Abstract available


  35. JARDINE AG, Hartmann A, Holdaas H
    Long-term renal allograft survival: a quiet revolution.
    Kidney Int. 2018;94:853-855.
    PubMed     Text format     Abstract available


    October 2018
  36. SANTORIELLO D, Husain SA, De Serres SA, Bomback AS, et al
    Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
    Kidney Int. 2018 Oct 2. pii: S0085-2538(18)30481.
    PubMed     Text format     Abstract available


  37. COZZI E, Biancone L
    C1q-binding donor-specific antibody assays help define risk and prognosis in antibody-mediated rejection.
    Kidney Int. 2018;94:657-659.
    PubMed     Text format     Abstract available


    September 2018
  38. CASPER J, Schmitz J, Brasen JH, Khalifa A, et al
    Renal transplant recipients receiving loop diuretic therapy have increased urinary tract infection rate and altered medullary macrophage polarization marker expression.
    Kidney Int. 2018 Sep 22. pii: S0085-2538(18)30516.
    PubMed     Text format     Abstract available


    August 2018
  39. FRANCIS A, Johnson DW, Craig J, Teixeira-Pinto A, et al
    Post-transplant lymphoproliferative disease may be an adverse risk factor for patient survival but not graft loss in kidney transplant recipients.
    Kidney Int. 2018 Aug 26. pii: S0085-2538(18)30446.
    PubMed     Text format     Abstract available


    July 2018
  40. COEMANS M, Susal C, Dohler B, Anglicheau D, et al
    Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015.
    Kidney Int. 2018 Jul 20. pii: S0085-2538(18)30392.
    PubMed     Text format     Abstract available


    June 2018
  41. LANDWEHR-KENZEL S, Zobel A, Hoffmann H, Landwehr N, et al
    Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy.
    Kidney Int. 2018;93:1452-1464.
    PubMed     Text format     Abstract available


    May 2018
  42. KOPP JB
    Global glomerulosclerosis in primary nephrotic syndrome: including age as a variable to predict renal outcomes.
    Kidney Int. 2018;93:1043-1044.
    PubMed     Text format     Abstract available


  43. NADA R, Ramachandran R, Kumar A, Gupta KL, et al
    Tumoral masses in failed kidneys.
    Kidney Int. 2018;93:1253.
    PubMed     Text format    


    April 2018
  44. SAID SM, Cosio FG, Valeri AM, Leung N, et al
    Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft.
    Kidney Int. 2018 Apr 28. pii: S0085-2538(18)30175.
    PubMed     Text format     Abstract available


  45. TANER T, Gustafson MP, Hansen MJ, Park WD, et al
    Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year.
    Kidney Int. 2018 Apr 12. pii: S0085-2538(18)30135.
    PubMed     Text format     Abstract available


    March 2018
  46. BATAL I, Mohan S, De Serres SA, Vasilescu ER, et al
    Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
    Kidney Int. 2018 Mar 13. pii: S0085-2538(18)30059.
    PubMed     Text format     Abstract available


  47. GREENLEAF E, Farooq U, Jain A, DiCristina R, et al
    Native kidney pyelonephritis as the cause of recurrent urinary tract infections in a kidney transplant recipient.
    Kidney Int. 2018;93:762.
    PubMed     Text format    


  48. SIVAYOGANATHAN S, Ariyawansa D, Ambawatte P, Galahitiyawa C, et al
    A rare presentation of a posttransplant lymphoproliferative disorder.
    Kidney Int. 2018;93:761.
    PubMed     Text format    


    February 2018
  49. DURAND M, Dubois F, Dejou C, Durand E, et al
    Increased degradation of ATP is driven by memory regulatory T cells in kidney transplantation tolerance.
    Kidney Int. 2018 Feb 15. pii: S0085-2538(18)30001.
    PubMed     Text format     Abstract available


  50. REICH B, Viehmann SF, Kurts C
    Plasmacytoid dendritic cells: important players in human kidney allograft rejection.
    Kidney Int. 2018;93:301-303.
    PubMed     Text format     Abstract available


  51. RUBEN JM, Garcia-Romo GS, Breman E, van der Kooij S, et al
    Human plasmacytoid dendritic cells acquire phagocytic capacity by TLR9 ligation in the presence of soluble factors produced by renal epithelial cells.
    Kidney Int. 2018;93:355-364.
    PubMed     Text format     Abstract available


  52. HEIDT S, Haasnoot GW, van Rood JJ, Witvliet MD, et al
    Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
    Kidney Int. 2018;93:491-500.
    PubMed     Text format     Abstract available


    January 2018
  53. CHUTE DF, Chung RT, Sise ME
    Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30807.
    PubMed     Text format     Abstract available


  54. RODELO-HAAD C, Aguera ML, Ortega R, Martinez-Lopez A, et al
    Lithium-associated nephropathy in the renal allograft.
    Kidney Int. 2018;93:273.
    PubMed     Text format    


  55. ETTA PK, Rao MV
    Gas in a renal allograft: think beyond!
    Kidney Int. 2018;93:272.
    PubMed     Text format    


    December 2017
  56. LI J, Basler M, Alvarez G, Brunner T, et al
    Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
    Kidney Int. 2017 Dec 4. pii: S0085-2538(17)30773.
    PubMed     Text format     Abstract available


    October 2017
  57. LIM WH, Wong G, Heidt S, Claas FHJ, et al
    Novel aspects of epitope matching and practical application in kidney transplantation.
    Kidney Int. 2017 Oct 20. pii: S0085-2538(17)30604.
    PubMed     Text format     Abstract available


    September 2017
  58. YACOUB R, Nadkarni GN, Cravedi P, He JC, et al
    Analysis of OPTN/UNOS registry suggests the number of HLA matches and not mismatches is a stronger independent predictor of kidney transplant survival.
    Kidney Int. 2017 Sep 28. pii: S0085-2538(17)30547.
    PubMed     Text format     Abstract available


  59. PEARL MH, Zhang Q, Palma Diaz MF, Grotts J, et al
    Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation.
    Kidney Int. 2017 Sep 16. pii: S0085-2538(17)30509.
    PubMed     Text format     Abstract available


  60. MENGEL M
    Deconstructing interstitial fibrosis and tubular atrophy: a step toward precision medicine in renal transplantation.
    Kidney Int. 2017;92:553-555.
    PubMed     Text format     Abstract available


    August 2017
  61. DE FIJTER JW
    Recurrence of glomerulonephritis: an underestimated and unmet medical need.
    Kidney Int. 2017;92:294-296.
    PubMed     Text format     Abstract available


    July 2017
  62. BROCKLEBANK V, Johnson S, Sheerin TP, Marks SD, et al
    Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30323.
    PubMed     Text format     Abstract available


  63. KENTRUP D, Bovenkamp P, Busch A, Schuette-Nuetgen K, et al
    GlucoCEST magnetic resonance imaging in vivo may be diagnostic of acute renal allograft rejection.
    Kidney Int. 2017 Jul 11. pii: S0085-2538(17)30303.
    PubMed     Text format     Abstract available


    June 2017
  64. ALLEN PJ, Chadban SJ, Craig JC, Lim WH, et al
    Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes.
    Kidney Int. 2017 Jun 7. pii: S0085-2538(17)30208.
    PubMed     Text format     Abstract available


  65. CLAYTON PA, Coates PT
    Are sensitized patients better off with a desensitization transplant or waiting on dialysis?
    Kidney Int. 2017;91:1266-1268.
    PubMed     Text format     Abstract available


    May 2017
  66. HAAS M
    Simultaneous liver-kidney transplantation: shifting renal allograft gene expression from inflammation toward preservation.
    Kidney Int. 2017;91:1010-1013.
    PubMed     Text format     Abstract available


  67. MJOEN G, Holdaas H
    Regarding "Obesity increases the risk of end-stage renal disease among living kidney donors".
    Kidney Int. 2017;91:1256.
    PubMed     Text format    


    April 2017
  68. GILL J, Rose C, Joffres Y, Kadatz M, et al
    Cold ischemia time up to 16 hours has little impact on living donor kidney transplant outcomes in the era of kidney paired donation.
    Kidney Int. 2017 Apr 19. pii: S0085-2538(17)30105.
    PubMed     Text format     Abstract available


  69. SCHAUERTE C, Hubner A, Rong S, Wang S, et al
    Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction.
    Kidney Int. 2017 Apr 8. pii: S0085-2538(17)30117.
    PubMed     Text format     Abstract available


  70. NADKARNI GN, Wyatt CM, Murphy B, Ross MJ, et al
    APOL1: a case in point for replacing race with genetics.
    Kidney Int. 2017;91:768-770.
    PubMed     Text format     Abstract available


  71. WIJKSTROM M, Iwase H, Paris W, Hara H, et al
    Renal xenotransplantation: experimental progress and clinical prospects.
    Kidney Int. 2017;91:790-796.
    PubMed     Text format     Abstract available


    March 2017
  72. LAM NN, Tonelli M, Lentine KL, Hemmelgarn B, et al
    Albuminuria and posttransplant chronic kidney disease stage predict transplant outcomes.
    Kidney Int. 2017 Mar 30. pii: S0085-2538(17)30093.
    PubMed     Text format     Abstract available


  73. BRASEN JH, Khalifa A, Schmitz J, Dai W, et al
    Macrophage density in early surveillance biopsies predicts future renal transplant function.
    Kidney Int. 2017 Mar 27. pii: S0085-2538(17)30094.
    PubMed     Text format     Abstract available


  74. SICARD A, Meas-Yedid V, Rabeyrin M, Koenig A, et al
    Computer-assisted topological analysis of renal allograft inflammation adds to risk evaluation at diagnosis of humoral rejection.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30038.
    PubMed     Text format     Abstract available


  75. RAVINDRAN A, Go RS, Fervenza FC, Sethi S, et al
    Thrombotic microangiopathy associated with monoclonal gammopathy.
    Kidney Int. 2017;91:691-698.
    PubMed     Text format     Abstract available


    February 2017
  76. SHIU KY, McLaughlin L, Rebollo-Mesa I, Zhao J, et al
    Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-gamma production by Th1 cells.
    Kidney Int. 2017;91:477-492.
    PubMed     Text format     Abstract available


    January 2017
  77. HAAS M, Mirocha J, Reinsmoen NL, Vo AA, et al
    Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Kidney Int. 2017 Jan 16. pii: S0085-2538(16)30656.
    PubMed     Text format     Abstract available


    December 2016
  78. LOCKE JE, Reed RD, Massie A, MacLennan PA, et al
    Obesity increases the risk of end-stage renal disease among living kidney donors.
    Kidney Int. 2016 Dec 29. pii: S0085-2538(16)30613.
    PubMed     Text format     Abstract available


  79. LITJENS NH, Boer K, Zuijderwijk JM, Klepper M, et al
    Natural regulatory T cells from patients with end-stage renal disease can be used for large-scale generation of highly suppressive alloantigen-specific Tregs.
    Kidney Int. 2016 Dec 14. pii: S0085-2538(16)30599.
    PubMed     Text format     Abstract available


    October 2016
  80. CHERUKURI A, Salama AD, Carter CR, Landsittel D, et al
    Reduced human transitional B cell T1/T2 ratio is associated with subsequent deterioration in renal allograft function.
    Kidney Int. 2016 Oct 28. pii: S0085-2538(16)30481.
    PubMed     Text format     Abstract available


    August 2016
  81. BIENAIME F, Legendre C, Terzi F, Canaud G, et al
    Antiphospholipid syndrome and kidney disease.
    Kidney Int. 2016 Aug 20. pii: S0085-2538(16)30317.
    PubMed     Text format     Abstract available


    June 2016
  82. CHEN T, Cleland B, Nankivell BJ
    The Case | Rapidly progressing polyneuropathy in a dialysis patient.
    Kidney Int. 2016;89:1409-10.
    PubMed     Text format    


    May 2016
  83. DRAGUN D, Catar R, Philippe A
    Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
    Kidney Int. 2016 May 14. pii: S0085-2538(16)30071.
    PubMed     Text format     Abstract available


  84. ROMANOWSKI K, Clark EG, Levin A, Cook VJ, et al
    Tuberculosis and chronic kidney disease: an emerging global syndemic.
    Kidney Int. 2016 May 10. pii: S0085-2538(16)30053.
    PubMed     Text format     Abstract available


  85. MA L, Langefeld CD, Comeau ME, Bonomo JA, et al
    APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
    Kidney Int. 2016 May 5. pii: S0085-2538(16)30012.
    PubMed     Text format     Abstract available


    April 2016
  86. ZHANG L, Lee G, Liu X, Pascoe EM, et al
    Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
    Kidney Int. 2016 Apr 8. pii: S0085-2538(16)00363.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: